Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $491.99 | 20 | 93.4% |
| Education | $34.69 | 4 | 6.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $196.06 | 7 | $0 (2020) |
| Boston Scientific Corporation | $133.68 | 5 | $0 (2024) |
| Amgen Inc. | $57.58 | 4 | $0 (2021) |
| Novo Nordisk Inc | $40.43 | 2 | $0 (2021) |
| AbbVie Inc. | $37.14 | 2 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $33.50 | 2 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $14.20 | 1 | $0 (2020) |
| Orexigen Therapeutics, Inc. | $14.09 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.28 | 1 | Boston Scientific Corporation ($33.28) |
| 2023 | $22.61 | 1 | Boston Scientific Corporation ($22.61) |
| 2022 | $24.95 | 1 | Boston Scientific Corporation ($24.95) |
| 2021 | $96.07 | 4 | BOSTON SCIENTIFIC CORPORATION ($40.84) |
| 2020 | $51.28 | 3 | Amarin Pharma Inc. ($19.00) |
| 2019 | $25.57 | 2 | Janssen Pharmaceuticals, Inc ($13.57) |
| 2018 | $61.84 | 4 | Amgen Inc. ($45.73) |
| 2017 | $211.08 | 8 | Amarin Pharma Inc. ($177.06) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $33.28 | General |
| Category: General - Pain Management_NMD | ||||||
| 04/06/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: General - Pain Management_NMD | ||||||
| 11/10/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: General - Pain Management_NMD | ||||||
| 08/17/2021 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Inflammation | ||||||
| 05/06/2021 | BOSTON SCIENTIFIC CORPORATION | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $40.84 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/07/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2021 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Obesity | ||||||
| 10/05/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Diabetes | ||||||
| 08/05/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Cardiovascular | ||||||
| 05/30/2019 | Boston Scientific Corporation | GENERAL PAIN MANAGEMENT (Device) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 04/08/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/28/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Neuroscience | ||||||
| 07/19/2018 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Neuroscience | ||||||
| 04/18/2018 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Endocrinology | ||||||
| 01/23/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Cardiology | ||||||
| 11/15/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/15/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $10.28 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/15/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $10.28 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/24/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/24/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $10.28 | General |
| Category: Hypertriglyceridemia | ||||||
| 08/24/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $3.85 | General |
| Category: Hypertriglyceridemia | ||||||
| 07/27/2017 | Orexigen Therapeutics, Inc. | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: OBESITY | ||||||
| 04/21/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.93 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 566 | 1,012 | $151,109 | $77,387 |
| 2022 | 9 | 423 | 876 | $137,992 | $62,065 |
| 2021 | 9 | 610 | 1,194 | $163,081 | $72,584 |
| 2020 | 7 | 470 | 1,141 | $183,592 | $71,394 |
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 160 | 583 | $107,831 | $46,932 | 43.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 124 | 124 | $17,980 | $15,271 | 84.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 137 | 144 | $7,860 | $6,192 | 78.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 14 | $4,900 | $2,934 | 59.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 20 | $4,540 | $2,736 | 60.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 27 | $4,059 | $1,374 | 33.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 39 | 39 | $1,644 | $1,068 | 65.0% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 40 | 40 | $1,917 | $808.69 | 42.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 21 | $378.00 | $71.61 | 18.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 191 | 628 | $113,038 | $49,720 | 44.0% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 13 | 15 | $4,500 | $2,224 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 32 | $4,800 | $1,970 | 41.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 68 | 71 | $2,982 | $1,931 | 64.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 15 | 15 | $2,175 | $1,876 | 86.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 14 | 14 | $4,284 | $1,491 | 34.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 69 | 72 | $3,500 | $1,475 | 42.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 11 | $2,388 | $1,317 | 55.1% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 18 | $324.00 | $61.71 | 19.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 204 | 702 | $129,870 | $58,369 | 44.9% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 160 | 195 | $9,407 | $4,048 | 43.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 50 | $7,500 | $3,398 | 45.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 15 | 21 | $6,300 | $3,248 | 51.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 80 | 80 | $3,360 | $1,259 | 37.5% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 52 | 52 | $2,575 | $1,068 | 41.5% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 29 | 29 | $1,218 | $577.39 | 47.4% |
About Dr. Patsy Mitchell, D.O
Dr. Patsy Mitchell, D.O is a Family Medicine healthcare provider based in Brunswick, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1588720601.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patsy Mitchell, D.O has received a total of $526.68 in payments from pharmaceutical and medical device companies, with $33.28 received in 2024. These payments were reported across 24 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($491.99).
As a Medicare-enrolled provider, Mitchell has provided services to 2,069 Medicare beneficiaries, totaling 4,223 services with total Medicare billing of $283,430. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Brunswick, GA
- Active Since 01/01/2007
- Last Updated 01/15/2015
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1588720601
Products in Payments
- Vascepa (Drug) $196.06
- GENERAL PAIN MANAGEMENT (Device) $40.84
- XARELTO (Drug) $33.50
- Aimovig (Biological) $31.55
- General - Pain Management (Device) $24.95
- Saxenda (Drug) $22.35
- SYNTHROID (Drug) $21.03
- Ozempic (Drug) $18.08
- Androgel (Drug) $16.11
- TRINTELLIX (Drug) $14.20
- Repatha (Biological) $14.18
- CONTRAVE (Drug) $14.09
- GENERAL PAIN MANAGEMENT (Device) $12.00
- Otezla (Drug) $11.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Brunswick
James Fleming, M.d, M.D
Family Medicine — Payments: $6,870
Michael Macdonald, Md, MD
Family Medicine — Payments: $5,525
Leonard Kinland, M.d, M.D
Family Medicine — Payments: $5,252
Dr. John Blumer, M.d, M.D
Family Medicine — Payments: $4,731
Mark Meacham, Md, MD
Family Medicine — Payments: $3,673
Jelisa Carroll
Family Medicine — Payments: $3,544